Litcius/Paper detail

Nonvalvular atrial fibrillation patients anticoagulated with rivaroxaban compared with warfarin exhibit reduced circulating extracellular vesicles with attenuated pro‐inflammatory protein signatures

Luisa Weiß, John F. Keaney, Paulina B. Szklanna, Tadhg Prendiville, Wido Uhrig, Kieran Wynne, Sarah Kelliher, Karl Ewins, Shane P. Comer, Karl Egan, Ellen O’Rourke, Eric Moran, Georgi Petrov, Ashish Patel, Áine Lennon, Alfonso Blanco, Barry Kevane, Séan Murphy, Fionnuala Ní Áinle, Patricia B. Maguire

2021Journal of Thrombosis and Haemostasis16 citationsDOI

Topics & Concepts

RivaroxabanAtrial fibrillationWarfarinExtracellular vesiclesMedicinePharmacologyCardiologyExtracellular vesicleExtracellularInternal medicineChemistryBiochemistryMicrovesiclesBiologyCell biologymicroRNAGeneExtracellular vesicles in diseaseAtrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management
Nonvalvular atrial fibrillation patients anticoagulated with rivaroxaban compared with warfarin exhibit reduced circulating extracellular vesicles with attenuated pro‐inflammatory protein signatures | Litcius